Structure Therapeutics Inc (GPCR) Directors and Executive Officers - CSIMarket
CSIMarket
 
Structure Therapeutics Inc   (NASDAQ: GPCR)

Structure Therapeutics Inc

Officers & Directors


Yoon
Chief Financial Officer and Director

Daniel Welch
Chairman

Sharon Tetlow
Director

Raymond Stevens, Ph.D.
Chief Executive Officer and Director

Eric Dobmeier
Director

Ramy Farid, Ph.D.
Director

Ted W. Love, M.D.
Director

Joanne Waldstreicher, M.D.
Director


San Jose, California ,

Structure Therapeutics Inc currently has 220 employees.

  News about Structure Therapeutics Inc Key Personnel

Structure Therapeutics Unveils Ambitious Public Offering Plans, Aiming to Revolutionize Biopharmaceutical Industry

Structure Therapeutics Announces Proposed Public Offering of American Depositary Shares and Pre-Funded Warrants
SAN FRANCISCO, June 03, 2024 - Structure Therapeutics Inc. (NASDAQ: GPCR), a leading biopharmaceutical company specializing in the development of innovative oral small molecule therapeutics for metabolic and cardiopulmonary diseases, has made an exciting announcement. The company recently filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC) for a proposed underwritten public offering.
The offering will consist of 8,000,000 American depositary shares (ADSs), with each ADS representing three ordinary shares. Structure Therapeutics also plans to off...






GPCR Management Effectiveness GPCR Revenue per Employee GPCR Income per Employee


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.